In The News - Volume 1 - Issue 3 - March 13, 2015

An Open Letter to HHS Secretary Burwell on Ethically Increasing Organ Donation
March 12 - Transplantation Direct - American and international leaders in the field of organ donation and transplantation, as well as jurists, ethicists, anthropologists and public health experts have urged the US Secretary of Human Health and Services to support renewed efforts to promote organ donation.  More

Correspondence - Organ transplantation in China - Jacob Lavee, Vivekanand Jha
March 7 - The Lancet- Chinese leaders have begun to bring their country's organ donation system into line with international standards—a challenging task. Although we strongly support these efforts, more needs to be known to justify the praise in the Editorial1 in The Lancet. More

New Bionic Heart Doesn't Beat and That's Why It Could Revolutionize Transplants
March 11- CNN - Scientists at the Texas Heart Institute say the perfect bionic heart is within their reach, but it doesn't beat. The average human heart has to beat 42 million times a year, which means that if it were replaced with a machine with a lot of moving parts, it would quickly wear out, said Dr. William Cohn, chief medical officer of BiVACOR, the company working on the new bionic heart. More

Peter Medawar's legacy to cellular immunology and clinical transplantation: a commentary on Billingham, Brent and Medawar (1956) ‘Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance’
March 6 - royalsocietypublishing.org - . The Philosophical Transactions B 1956 paper is clothed with an astonishing amount of further experimental detail. It is written in Peter Medawar's landmark style: witty, perceptive and full of images that can be recalled even when details of the supporting information have faded.  More

A Report From a Consensus Conference on Primary Graft Dysfunction in Heart Transplantation
Mar 11, 2015 | American College of Cardiology - At the 33rd annual International Society of Heart and Lung Transplant (ISHLT) meeting, a consensus conference was convened to formulate guidelines regarding primary graft dysfunction (PGD) after heart transplantation. The conference included a summary of survey data collected before the conference, state-of-the-art presentations given at the consensus conference, and consensus statements drawn from group sessions. Each of these areas will be summarized in this review.  More

Study shows even injured kidneys can be used for transplants
March 11 - Yale News -Kidneys from deceased donors that have acute injuries are frequently discarded instead of being used for transplant. However, a Yale-led study finds that such kidneys may be more viable than previously thought, and should be considered to meet the growing demand for organ transplants. More

New strategy for preventing organ transplant rejection shows promise
March 10 - University of Michigan- Interrupting a key cellular signaling pathway for a short period of time immediately after transplantation significantly decreased rejection in a mouse model of heart transplantation, according to findings published in the Journal of Immunology. More

Chimpanzee Attack Survivor Charla Nash's New Face May Forever Change Transplant Surgery
March 11- Medical Daily - Due to the extent of her injuries, Nash became a candidate to become recipient of the novel complete face transplant, and in 2011 she received the innovative operation, fully funded by the U.S. government. The Pentagon’s involvement in Nash’s recovery did not end after surgery, however. Every six weeks Nash undergoes lab tests for the military, MRIs and CT scans, to determine how well her brain is sending signals to her new face, The Associated Press repored. The military doctors are also interested in how well Nash’s body is delivering blood to her new face and how her scars are healing. The next biggest hurdle in Nash’s recovery is coming off of the immunosuppression medication. In all organ transplants the recipient’s body will reject the foreign body part.  More

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi